Gemcitabine, fludarabine and melphalan for reduced-intensity conditioning and allogeneic stem cell transplantation for relapsed and refractory Hodgkin lymphoma

Forty patients with Hodgkin lymphoma underwent an allogeneic stem cell transplant with the gemcitabine-fludarabine-melphalan reduced-intensity conditioning regimen. The median age was 31 years (range 20–63). Thirty-one (77%) had undergone a prior autologous stem cell transplant, and the median time...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Biol Blood Marrow Transplant
Asıl Yazarlar: Anderlini, Paolo, Saliba, Rima M., Ledesma, Celina, Plair, Tamera, Alousi, Amin M., Hosing, Chitra M., Khouri, Issa F., Nieto, Yago, Popat, Uday R., Shpall, Elizabeth J, Fanale, Michelle A., Hagemeister, Frederick B., Oki, Yasuhiro, Neelapu, Saatva, Romaguera, Jorge E., Younes, Anas, Champlin, Richard E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5193224/
https://ncbi.nlm.nih.gov/pubmed/27064056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2016.03.028
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller